期刊文献+

儿童肥厚型心肌病的病因学进展 被引量:2

Progress in etiology of hypertrophic cardiomyopathy in children
原文传递
导出
摘要 儿童肥厚型心肌病(HCM)是一类常见的心血管遗传基因异常疾病,多数为单基因常染色体显性遗传性心肌病,也不排除其他遗传方式。HCM以心室对称性或非对称性肥厚为主要特征,组织病理学特点为心肌细胞肥大、排列紊乱以及纤维化。一般将儿童HCM分为原发性和继发性两种,原发性以编码肌小节蛋白基因突变为主要病因,非肌小节蛋白基因突变次之;其中肌小节性HCM以MYH7、MYBPC3、TNNT等基因突变为主。继发性病因包括肥胖、糖尿病母亲婴儿、运动员综合征、异常激素增高或药物诱发等。 Hypertrophic cardiomyopathy(HCM)in children is a kind of common cardiovascular genetic abnormalities disease,mostly single gene autosomal dominant inherited cardiomyopathy,although it does not exclude other genetic patterns. The main features of HCM are symmetrical or asymmetrical ventricular hypertrophy,and histopathological characteristics are myocyte hypertrophy,being disorganized,and fibrosis. Generally,HCM in children is divided into primary and secondary types. Mutation of sarcomere protein gene is the main cause of primary cardiomyopathy,followed by mutation of non-sarcomere protein gene.Mutation of MYH7,MYBPC3,TNNT and other genes are the main causes of sarcomere HCM. Secondary causes include obesity,diabetic mothers and babies,athlete syndrome,abnormal hormone elevation or drug-induced and so on.
作者 张小建 冯嵩 陈晓光 安金斗 ZHANG Xiao-jian;FENG Song;CHEN Xiao-guang(Department of Cardiology,the Hospital for Children, the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052, China)
出处 《中国实用儿科杂志》 CSCD 北大核心 2019年第5期347-352,共6页 Chinese Journal of Practical Pediatrics
关键词 肥厚型心肌病 基因突变 儿童 hypertrophic cardiomyopathy gene mutation child
  • 相关文献

参考文献1

二级参考文献13

  • 1心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:547
  • 2Richardson P, McKenna W, Bristow M, et al. Report of the 1995 WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation, 1996, 93: $41-842.
  • 3Maron B J, Towbin JA, Thienne G, et al. Contemporary definition and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and councilon epidemiology and prevention. Circulation, 2006, 113: 1807- 1816.
  • 4Elliott P, Anderson B, Arbustini E, et al. Classification of the cardiomyopathies : a position statement from the european society of cardiology working group on myocardial and pericardial diseas. Eur Heart J, 2008, 29: 270-276.
  • 5Thienne G, Angelini A, Basso C, et al. The new definition and classification of cardiomyopathies. Adv Clin Path, 2000, 4: 53- 57.
  • 6Colan SD. Classification of the cardiomyopathies. Prog Pediatr Cardiol, 2007, 23: 5-15.
  • 7E11iott P. The 2006 American Heart Association classification of cardiomyopathies is not the gold standard. Circ Heart Fail,2008, 1:77-80.
  • 8Colan SD, Lipshuhz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation, 2007, 115: 773-781.
  • 9马沛然.sldL心肌病诊治策略.北京:人民军医出版社,2011:256-262.
  • 10Miller TL, Neff D, Extein J, et al. Nutrition in pediatric eardiomyopathy. Prog Pediatr Cardiol, 2007, 24: 59-71.

共引文献4

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部